CEACAM1: A marker with a difference or more of the same?

Journal of Clinical Oncology

Volumn 20, Issue 21, 2002, Pages 4273-4275

  Plunkett, Timothy A ^a   Ellis, Paul A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; MOLECULAR MARKER; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

EDITORIAL; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036843294     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.21.4273     Document Type: Editorial

References (30)

1. Yip D, Harper PG: Predictive and prognostic factors in small cell lung cancer: Current status. Lung Cancer 28:173-185, 2000
2. Koutsami MK, Gorgoulis VG, Kastrinakis NG, et al: Prognostic factors in non-small cell lung carcinoma. Anticancer Res 22:347-374, 2002
3. Laack E, Nikbakht H, Peters A, et al: Expression of CEACAM1 in adenocarcinoma of the lung: A factor of independent prognostic significance. J Clin Oncol 20:4279-4284, 2002
4. Obrink B: CEA adhesion molecules: Multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol 9:616-626, 1997
5. Beauchemin N, Draber P, Dveksler G, et al: Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 252:243-249, 1999
6. Morales VM, Christ A, Watt SM, et al: Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J Immunol 163:1363-1370, 1999
7. Hauck CR, Meyer TF, Lang F, et al: CD66-mediated phagocytosis of Opa52 Neisseria gonorrhoeae requires a Src-like tyrosine kinase- and Racl-dependent signalling pathway. EMBO J 17:443-454, 1998
8. Riethdorf L, Lisboa BW, Henkel U, et al: Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 45:957-963, 1997
9. Neumaier M, Paululat S, Chan A, et al: Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci U S A 90:10744-10748, 1993
10. Kleinerman DI, Troncoso P, Lin SH, et al: Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: Implication as a tumor suppressor. Cancer Res 55:1215-1220, 1995
11. Bamberger AM, Riethdorf L, Nollau P, et al: Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 152:1401-1406, 1998
12. Luo W, Wood CG, Earley K, et al: Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): The adhesion and growth suppression are mediated by different domains. Oncogene 14:1697-1704, 1997
13. Luo W, Tapolsky M, Earley K, et al: Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther 6:313-321, 1999
14. Fournes B, Sadekova S, Turbide C, et al: The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity. Oncogene 20:219-230, 2001
15. Estrera VT, Chen DT, Luo W, et al: Signal transduction by the CEACAM1 tumor suppressor: Phosphorylation of serine 503 is required for growth-inhibitory activity. J Biol Chem 276:15547-15553, 2001
16. Thies A, Moll I, Berger J, et al: CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol 20:2530-2536, 2002
17. Ergun S, Kilik N, Ziegeler G, et al: CEA-related cell adhesion molecule 1: A potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5:311-320, 2000
18. Schumann D, Chen CJ, Kaplan B, et al: Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin. J Biol Chem 276:47421-47433, 2001
19. Brummer J, Ebrahimnejad A, Flayeh R, et al: cis interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am J Pathol 159:537-546, 2001
20. Kammerer R, Hahn S, Singer BB, et al: Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: Structure, expression and involvement in T cell activation. Eur J Immunol 28:3664-3674, 1998
21. Donda A, Mori L, Shamshiev A, et al: Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur J Immunol 30:2593-2603, 2000
22. Boulton IC, Gray-Owen SD: Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 3:229-236, 2002
23. Markel G, Lieberman N, Katz G, et al: CD66a interactions between human melanoma and NK cells: A novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 168:2803-2810, 2002
24. Bamberger AM, Kappes H, Methner C, et al: Expression of the adhesion molecule CEACAM1 (CD66a, BGP, C-CAM) in breast cancer is associated with the expression of the tumor-suppressor genes Rb, Rb2, and p27. Virchows Arch 440:139-144, 2002
25. Ramaswamy S, Golub TR: DNA microarrays in clinical oncology. J Clin Oncol 20:1932-1941, 2002
26. Garber ME, Troyanskaya OG, Schluens K, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 98:13784-13789, 2001
27. Bhattachadee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98:13790-13795, 2001
28. Mills JC, Roth KA, Cagan RL, et al: DNA microarrays and beyond: Completing the journey from tissue to cell. Nat Cell Biol 3:E175-E178, 2001
29. Volm M, Koomagi R, Mattern J, et al: Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res 8:1843-1848, 2002
30. Bremnes RM, Veve R, Gabrielson E, et al: High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 20:2417-2428, 2002